BioPhy provides an enterprise AI platform that automates regulatory compliance, SOP management, and validation processes for pharmaceutical companies. Its modular tools use natural‑language processing and machine learning to identify documentation gaps, score compliance risk, and accelerate IQ/OQ/PQ cycles, cutting manual review time by up to 65%. The unified dashboard integrates with existing quality and manufacturing workflows, delivering actionable insights and faster, data‑driven decision making.
Funding
$6.6M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
MVFounders
Product
Problem
Pharmaceutical companies spend millions annually on manual quality control, documentation errors, and fragmented SOPs, leading to regulatory risk, operational inefficiencies, and delayed product development.
Solution
BioPhy offers an enterprise AI platform that automates critical compliance and operational tasks across pharma. Its modular solutions—Regulatory Gap Analyzer, SOP Consolidator, and Validation Accelerator—use natural‑language processing and machine‑learning to compare SOPs against regulations, detect document duplication, and streamline validation protocols. The platform generates risk scores, remediation recommendations, and version‑control insights, reducing manual review time by up to 65% and accelerating IQ/OQ/PQ cycles by months. Results are delivered through a unified dashboard that integrates with existing quality, manufacturing, and validation workflows, enabling faster, data‑driven decision making while maintaining regulatory compliance.
Target Audience
Primary customers are quality assurance, regulatory affairs, and manufacturing teams within pharmaceutical companies that manage SOPs, validation processes, and compliance documentation.
Features
- AI‑driven regulatory gap analysis that automatically aligns SOPs with current FDA and global regulations
- Compliance risk scoring and actionable remediation recommendations to prioritize corrective actions
- Document similarity detection and cross‑regional consistency checks to eliminate SOP duplication
- Version‑control monitoring with change‑impact analysis for continuous SOP governance
- Validation acceleration tools that automate IQ/OQ/PQ data extraction and reporting, shortening validation timelines
- Modular architecture allowing pharma sites to deploy individual solutions or the full platform as needed